Skip to main content

Okla. Vs. J&J Opioid-Crisis Trial Wrapped

Okla. Vs. J&J Opioid-Crisis Trial Wrapped

Okla. Vs. J&J Opioid-Crisis Trial Wrapped

Introduction

Trial testimony in the high-profile case involving Johnson & Johnson (J&J) and Oklahoma state over the ravages of the opioid crisis ended on Monday.

Following eight weeks of testimony, attorneys representing the state and the pharmaceutical giant have made their final arguments in a historic bench trial. During the trial, J&J argued for an early win claiming that the state failed to produce enough evidence to support its case, whereas the state compared the defendants to 'kingpin' for fuelling the U.S. opioid epidemic. J&J had filed a motion to dismiss the lawsuit in the early weeks of the month, which was later dismissed by Oklahoma District Judge Thad Balkman. The state urged Judge Thad Balkman, to find J&J liable for the epidemic and force it to pay up to $17 billion over 30 years.

Judge Balkman affirmed that he would rule after receiving briefs from both sides due July 31.

U.S. District Judge Dan Polster is presiding over all opioid lawsuits consolidated under MDL No. 2804 (In Re: National Prescription Opiate Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!